Historical shareholding details of T. Rowe Price New Horizons Fund holdings in MoonLake Immunotherapeutics - Ordinary Shares - Class A (MLTX)

Monthly changes of T. Rowe Price New Horizons Fund shareholding in MoonLake Immunotherapeutics - Ordinary Shares - Class A over the previous months

Month	Name	Total no. shares held	Percent Holding
Month	Name	Total no. shares held	Percent Holding
Jan 31, 2025	T. Rowe Price New Horizons Fund	666,983	1.05%

Dec 31, 2024	T. Rowe Price New Horizons Fund	667,176	1.05%

Nov 30, 2024	T. Rowe Price New Horizons Fund	667,176	1.06%

Oct 31, 2024	T. Rowe Price New Horizons Fund	667,316	1.06%

Sep 30, 2024	T. Rowe Price New Horizons Fund	667,750	1.06%

Aug 31, 2024	T. Rowe Price New Horizons Fund	625,816	1.00%

Jun 30, 2024	T. Rowe Price New Horizons Fund	626,069	1.00%

Mar 31, 2024	T. Rowe Price New Horizons Fund	522,634	0.83%

Dec 31, 2023	T. Rowe Price New Horizons Fund	674,911	1.07%

Sep 30, 2023	T. Rowe Price New Horizons Fund	677,069	1.13%

Jun 30, 2023	T. Rowe Price New Horizons Fund	677,330	1.27%